No Prescription |
 |
 | ||
|
NEOCALM Stelazine |
|
| ||
No Prescription » Prescription Drugs 11 » NEOCALM Stelazine Trifluoperazine is used to treat schizophrenia and symptoms such as hallucinations delusions and hostility. It is also used short-term to treat anxiety in some patients.Trifluoperazine comes as a tablet and liquid concentrate to take by mouth. It usually is taken one or two times a day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take trifluoperazine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.The liquid concentrate must be diluted before use. It comes with a specially marked dropper for measuring the dose. Ask your pharmacist to show you how to use the dropper if you have difficulty. To dilute the liquid concentrate add it to at least 2 ounces of milk water soft drink coffee tea tomato or fruit juice soup or pudding just before you take it. If any beverage soup or pudding gets on the dropper rinse the dropper with tap water before replacing it in the bottle. Do not allow the liquid concentrate to touch your skin or clothing; it can irritate your skin. If you spill the liquid concentrate on your skin wash it off immediately with soap and water.Continue to take trifluoperazine even if you feel well. Do not stop taking trifluoperazine without talking to your doctor especially if you have taken large doses for a long time. Your doctor probably will decrease your dose gradually. This drug must be taken regularly for a few weeks before its full effect is felt. Buy NEOCALM Stelazine and other Prescription Drugs 11 products online at Medstore. 825
About NEOCALM Stelazine: Product Type: Prescription Drugs 11 NEOCALM ( Stelazine Generic Trifluoperazine ) NEOCALM (Stelazine Generic Trifluoperazine) Stelazine Generic Trifluoperazine 5mg Tabs 30 (3 x 10) Stelazine Generic Trifluoperazine NEOCALM
View more Prescription Drugs 11 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
